| Summary: | Advanced glycation end products (AGEs) have been implicated in the pathophysiology of type 2 diabetes and cardiovascular disease. We aimed to determine the associations of urinary carboxymethyl-lysine (CML) and methylglyoxal-hydroimidazolone (MG-H1) levels with cardiometabolic parameters in metabolically healthy obese women. Anthropometric, glycemic, cardiovascular, and urinary AGE parameters were measured in 58 metabolically healthy obese women (age: 39.98 ± 8.72 years; body mass index (BMI): 32.29 ± 4.05 kg/m<sup>2</sup>). Urinary CML levels were positively associated with BMI (<i>r</i> = 0.29, <i>p</i> = 0.02). After adjustment for age and BMI, there was a trend for positive associations between urinary CML levels and fasting (<i>p</i> = 0.06) and 2 h insulin (<i>p</i> = 0.05) levels, and insulin resistance measured by homeostatic model assessment (HOMA-IR) (<i>p</i> = 0.06). Urinary MG-H1 levels were positively associated with systolic and diastolic blood pressure, pulse pressure, mean arterial pressure, and total and low-density lipoprotein cholesterol after adjustment for age, BMI, and HOMA-IR (all <i>p</i> ˂ 0.05). There were no associations between urinary CML levels and cardiovascular parameters, and between urinary MG-H1 levels and glycemic measurements. Our data support a role of urinary AGEs in the pathophysiology of insulin resistance and cardiovascular disease; however, future studies are highly warranted.
|
|---|
